Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

# News

Our New Resource Page for Pulmonary Lymphoepithelioma-like Carcinoma

Primary Pulmonary Lymphoepithelioma-like Carcinoma (LELC) is a rare type of non-small cell lung cancer (NSCLC) that closely resembles nasopharyngeal carcinoma. This cancer is strongly linked to the Epstein-Barr virus (EBV), particularly in Asian populations. Because...

Our New Resource Page for Primary Melanocytic Tumour

Primary Melanocytic Tumour of the central nervous system (CNS) are rare tumours arising from melanocytes in the thin layers surrounding the brain and spinal cord. These tumours range from slow-growing melanocytomas, which have a favourable prognosis, to aggressive...

Our New Resource Page for Papillary Glioneuronal Tumour

Papillary Glioneuronal Tumour (PGNT) is a rare, low-grade central nervous system (CNS) tumour characterised by a mix of glial and neuronal components. Many sufferers of Papillary Glioneuronal Tumour struggle because they feel that their disease doesn’t have the...

Our New Resource Page for Primary Peritoneal Carcinoma of the Abdomen

Primary Peritoneal Carcinoma of the Abdomen is a rare cancer that begins in the peritoneum, which is a thin tissue that lines the abdomen and protects organs such as the bladder, intestines, and uterus. It develops when cells in the lining grow abnormally. Many...

Our New Resource Page for Sebaceous Gland Carcinoma of the Eyelid

Sebaceous gland carcinoma (SGC) of the eyelid is a rare but aggressive type of cancer that originates from the oil-producing (sebaceous) glands in the eyelids. These glands help keep the eyes moist and protect against infections. SGC is the second most common eyelid...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter